Interventional Cardiology and Peripheral Vascular Devices Market by Product Type (Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Accessories, Angioplasty Balloons, Angioplasty Stents, Angioplasty Cathet

Interventional Cardiology and Peripheral Vascular Devices Market by Product Type (Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Accessories, Angioplasty Balloons, Angioplasty Stents, Angioplasty Catheters, Endovascular Aneurysm Repair Stent Grafts), Indication (Coronary Intervention, Peripheral Arterial Disease), Age Group (Geriatric, Adults, Paediatric), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032


The global interventional cardiology and peripheral vascular devices market size reached US$ 25.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 47.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.07% during 2024-2032. The increasing number of individuals suffering from chronic heart conditions, surging incidences of peripheral arterial disease (PAD), and rising consumer preferences for minimally invasive (MI) procedures represent some of the key factors driving the market.

Interventional cardiology refers to the sub-specialty of cardiology that relies on intravascular catheter-based techniques with fluoroscopy to treat numerous valvular, coronary artery, and congenital heart diseases. On the other hand, peripheral vascular devices are medical devices used for treating artery blockages and narrowing of blood vessels, especially in the peripheral vasculature, resulting in reduced blood flow to different body parts. These interventional methods are commonly employed for managing cardiology diseases and peripheral vascular disorders affecting the circulatory system to avoid complications and scars while minimizing pain and promoting faster recovery. As a result, interventional cardiology and peripheral vascular devices find extensive applications in the treatment of various structural heart diseases and artery-related ailments, as well as in peripheral endovascular and coronary procedures.

Interventional Cardiology and Peripheral Vascular Devices Market Trends:
The increasing number of individuals suffering from chronic heart conditions, such as coronary artery diseases (CADs), has strengthened the need for early detection and intervention to prevent fatal consequences. This, coupled with the rising incidences of peripheral arterial disease (PAD), represents the primary factor driving the market growth. Additionally, there has been a substantial shift from traditional surgeries toward minimally invasive (MI) procedures among patients and healthcare professionals as they involve smaller incisions, less surgical pain, injury, and scarring, shorter hospital stays, higher accuracy, and quick recovery. In line with this, the expanding geriatric population is contributing to the growing burden of cardiological and vascular diseases across the globe, which in turn has augmented the product demand. Furthermore, due to rapid technological advancements, the leading manufacturers are developing new and innovative variants of interventional cardiology and peripheral vascular devices for better treatment outcomes. Along with this, continuous product launches by key players and the increasing number of product approvals have propelled market growth. Other factors, including the introduction of bio-absorbable stents, rising admission cases in emergency and critical care, favorable reimbursement policies, improving healthcare infrastructure, and ongoing research and development (R&D) activities, are also providing a positive thrust to the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global interventional cardiology and peripheral vascular devices market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, indication, age group, and end user.

Product Type Insights:

Inferior Vena Cava (IVC) Filters
Plaque Modification Devices
Hemodynamic Flow Alteration Devices
Accessories
Angioplasty Balloons
Angioplasty Stents
Angioplasty Catheters
Endovascular Aneurysm Repair Stent Grafts

The report has provided a detailed breakup and analysis of the interventional cardiology and peripheral vascular devices market based on the product type. This includes inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, accessories, angioplasty balloons, angioplasty stents, angioplasty catheters, and endovascular aneurysm repair stent grafts. According to the report, angioplasty balloons represented the largest segment.

Indication Insights:

Coronary Intervention
Peripheral Arterial Disease

A detailed breakup and analysis of the interventional cardiology and peripheral vascular devices market based on the indication has also been provided in the report. This includes coronary intervention and peripheral arterial disease.

Age Group Insights:

Geriatric
Adults
Paediatric

The report has provided a detailed breakup and analysis of the interventional cardiology and peripheral vascular devices market based on the age group. This includes geriatric, adults, and paediatric. According to the report, geriatric represented the largest segment.

End User Insights:

Hospitals
Ambulatory Surgical Centers
Others

The report has provided a detailed breakup and analysis of the interventional cardiology and peripheral vascular devices market based on the end user. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals represented the largest segment.

Regional Insights:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for interventional cardiology and peripheral vascular devices. Some of the factors driving the North America interventional cardiology and peripheral vascular devices market included its rapidly aging population, the presence of a large patient pool, increasing healthcare expenditure, etc.

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global interventional cardiology and peripheral vascular devices market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, B. Braun Melsungen AG, Becton Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Group Incorporated, Cordis Corporation, Koninklijke Philips N.V., Medtronic plc., Teleflex Incorporated, Terumo Corporation, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:
How has the global interventional cardiology and peripheral vascular devices market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global interventional cardiology and peripheral vascular devices market?
What is the impact of each driver, restraint, and opportunity on the global interventional cardiology and peripheral vascular devices market?
What are the key regional markets?
Which countries represent the most attractive interventional cardiology and peripheral vascular devices market?
What is the breakup of the market based on the product type?
Which is the most attractive product type in the interventional cardiology and peripheral vascular devices market?
What is the breakup of the market based on the indication?
Which is the most attractive indication in the interventional cardiology and peripheral vascular devices market?
What is the breakup of the market based on the age group?
Which is the most attractive age group in the interventional cardiology and peripheral vascular devices market?
What is the breakup of the market based on end user?
Which is the most attractive end user in the interventional cardiology and peripheral vascular devices market?
What is the competitive structure of the global interventional cardiology and peripheral vascular devices market?
Who are the key players/companies in the global interventional cardiology and peripheral vascular devices market?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Interventional Cardiology and Peripheral Vascular Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Inferior Vena Cava (IVC) Filters
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Plaque Modification Devices
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Hemodynamic Flow Alteration Devices
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Accessories
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Angioplasty Balloons
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Angioplasty Stents
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Angioplasty Catheters
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Endovascular Aneurysm Repair Stent Grafts
6.8.1 Market Trends
6.8.2 Market Forecast
7 Market Breakup by Indication
7.1 Coronary Intervention
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Peripheral Arterial Disease
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Age Group
8.1 Geriatric
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Adults
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Paediatric
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Ambulatory Surgical Centers
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 Drivers, Restraints, and Opportunities
11.1 Overview
11.2 Drivers
11.3 Restraints
11.4 Opportunities
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 B. Braun Melsungen AG
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 SWOT Analysis
15.3.3 Becton Dickinson and Company
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Biotronik SE & Co. KG
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 SWOT Analysis
15.3.5 Boston Scientific Corporation
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Cook Group Incorporated
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Cordis Corporation
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Koninklijke Philips N.V.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Medtronic plc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Teleflex Incorporated
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Terumo Corporation
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings